CMV p65 Antikörper

Produktnummer ABIN6941309

Produktdetails anti-CMV p65 Antikörper

Target: CMV p65 (Cytomegalovirus p65 (CMV p65))

Reaktivität: Human Herpesvirus 5 (HHV-5)

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser CMV p65 Antikörper ist unkonjugiert

Applikation: ELISA, Coating (Coat)

Aufreinigung: Purified by Protein A/G

Immunogen: Recombinant CMV-p65 protein

Klon: CMV100

Isotyp: IgG1 kappa

Anwendungsinformationen

Applikationshinweise:

Positive Control: CMV-infected cells. Tissues.

Known Application: ELISA (For coating use Ab at 1-5 μg/mL, order Ab without BSA), Optimal dilution for a specific application should be determined.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 200 μg/mL

Buffer: 10 mM PBS with 0.05 % BSA & 0.05 % azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C

Informationen zur Lagerung: Antibody with azide - store at 2 to 8°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

Haltbarkeit: 24 months

Details zu CMV p65

Target: CMV p65 (Cytomegalovirus p65 (CMV p65))

Andere Bezeichnung: Cytomegalovirus p65 (CMV-p65) (CMV p65 Produkte)

Substanzklasse: Viral Protein

Hintergrund: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Molekulargewicht: 65kDa